SPOTTER Selective aptamer probe for detecting and targeting multimolecular G-quadriplexes aggregates in amyotrophic lateral sclerosis (ALS) disease
- Coordinator
- Imperial College of Science Technology and Medicine, United Kingdom
- Runs
- 15 September 2025 to 14 September 2027
- Status
- Running
- EU funding
- €260k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101208854
What the project is doing
In the project's own words, from its summary on CORDIS.
G-quadruplex structures (G4s) are gaining attention due to their widespread presence in the human genome, featuring over 700,000 identified sequences. These stable G4s are often found in critical areas of our DNA, such as telomeres, gene promoters, and regions linked to repeat expansions in diseases. However, when investigating their biological function, multimolecular G-quadruplexes (mG4s) have been often overlooked and deemed unlikely to be physiologically relevant, with the bulk of recent advances on G4-biology almost exclusively focused on unimolecular G-quadriplexes (uG4s).
SPOTTER aims to fill this critical gap in the biology of mG4, by generating a selective probe that is currently missing to study these structures. Specifically, in this proposal, an aptamer-based probe that can be tuned to interact exclusively with mG4s will be developed. This tool will facilitate live-cell imaging and genome-wide mapping of mG4s for the very first time. This will further allow me to explore the role of mG4 formed in guanine-rich RNA repeat expansions, which could trigger formation of insoluble aggregates that are relevant to neurodegenerative diseases, such as in amyotrophic lateral sclerosis (ALS).
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Imperial College of Science Technology and Medicine | London | United Kingdom | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI